Home » Topics » BioWorld Science

BioWorld Science
RSS

Dana-Farber Cancer Institute discloses new HER2 inhibitors

April 29, 2022

Vertex Pharmaceuticals patents CFTR potentiators

April 29, 2022

University of California discloses new PRMT8 inhibitors

April 29, 2022

ProfoundBio presents novel ADCs for cancer treatment

April 29, 2022

Study finds targets of T-cell response in multiple sclerosis

April 28, 2022

Allogeneic NK-cell therapy CAT-179 useful for controlling HER2-positive tumors

April 28, 2022

AT-0174 IDO/TDO dual inhibitor shows promise for treating platinum-resistant NSCLC

April 28, 2022

Herantis reports blood-brain barrier penetration data with HER-096 in dogs

April 28, 2022

Medy-Tox patents new BTK inhibitors

April 28, 2022

University of Texas System identifies CBP and/or p300 inhibitors

April 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026